Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* Based on an updated review of several clinical trials, the Food and Drug Administration has concluded that the antidiabetic drug pioglitazone likely confers an increased risk of bladder cancer.

 

* Data from these trials will be added to the labeling of all products containing pioglitazone.